2,483 results on '"Moch, Holger"'
Search Results
2. Multi-resolution deep learning characterizes tertiary lymphoid structures and their prognostic relevance in solid tumors
3. Genomic alterations and diagnosis of renal cancer
4. Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study
5. Multielement Z-tag imaging by X-ray fluorescence microscopy for next-generation multiplex imaging
6. The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells
7. Immune Phenotype-Genotype Associations in Primary Clear Cell Renal Cell Carcinoma and Matched Metastatic Tissue
8. Männliche Geschlechtsorgane und ableitende Harnwege
9. Allgemeine Pathologie
10. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer
11. Prognostic impact of histological subtyping in triple-negative breast cancer
12. Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets
13. Biallelic ELOC-Inactivated Renal Cell Carcinoma: Molecular Features Supporting Classification as a Distinct Entity
14. Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors
15. Analysis of the PARP1, ADP-Ribosylation, and TRIP12 Triad With Markers of Patient Outcome in Human Breast Cancer
16. Immunohistochemical Expression Pattern of Theragnostic Targets SSTR2 and PSMA in Endolymphatic Sac Tumors: A Single Institution Case Series
17. Towards a national strategy for digital pathology in Switzerland
18. Multiplex imaging of breast cancer lymph node metastases identifies prognostic single-cell populations independent of clinical classifiers
19. Molekularpathologische Diagnostik des Harnblasenkarzinoms – prädiktive und prognostische Marker
20. Expert opinion on NSCLC small specimen biomarker testing — Part 2: Analysis, reporting, and quality assessment
21. Expert opinion on NSCLC small specimen biomarker testing — Part 1: Tissue collection and management
22. Genetic profiles of oligometastatic non-small cell lung cancer and corresponding brain metastases
23. Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients
24. Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours
25. Novel RGAG1-BCOR gene fusion revealed in a somatic soft tissue sarcoma with a long follow-up
26. Prognostic impact of tumour mutational burden in resected stage I and II lung adenocarcinomas from a European Thoracic Oncology Platform Lungscape cohort
27. Access and quality of biomarker testing for precision oncology in Europe
28. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors
29. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
30. The multispeciality approach to the management of localised kidney cancer
31. Three-dimensional imaging mass cytometry for highly multiplexed molecular and cellular mapping of tissues and the tumor microenvironment
32. A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy
33. Alterations in homologous recombination repair genes in prostate cancer brain metastases
34. Comparison of calling pipelines for whole genome sequencing: an empirical study demonstrating the importance of mapping and alignment
35. Biostatistical Aspects of Whole Genome Sequencing Studies: Preprocessing and Quality Control.
36. Author Correction: The landscape of viral associations in human cancers
37. YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases
38. What’s behind 68Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns
39. Establishing standardized immune phenotyping of metastatic melanoma by digital pathology
40. Heterogeneous and Novel Transcript Expression in Single Cells of Patient-Derived ccRCC Organoids
41. Comparison of Single-cell Long-read and Short-read Transcriptome Sequencing of Patient-derived Organoid Cells of ccRCC: Quality Evaluation of the MAS-ISO-seq Approach
42. High Grades of Amphiregulin Expression in Intestinal Tissue Samples of Pediatric Patients with Severe Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
43. The Role of Frozen Section Examination During Inguinal Exploration in Men with Inconclusive Testicular Tumors: A Systematic Review and Meta-analysis
44. Clinical implications of AGR2 in primary prostate cancer: Results from a large‐scale study
45. ERBB2‐amplified lobular breast carcinoma exhibits concomitant CDK12 co‐amplification associated with poor prognostic features
46. Cytoplasmic ADP-ribosylation levels correlate with markers of patient outcome in distinct human cancers
47. Tracing Clonal Dynamics Reveals that Two- and Three-dimensional Patient-derived Cell Models Capture Tumor Heterogeneity of Clear Cell Renal Cell Carcinoma
48. Chromophobe renal cell carcinoma: current and controversial issues
49. HNF1β is a sensitive and specific novel marker for yolk sac tumor: a tissue microarray analysis of 601 testicular germ cell tumors
50. Focal therapy with high‐intensity focused ultrasound for prostate cancer: 3‐year outcomes from a prospective trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.